[Skip to Content]
[Skip to Content Landing]
Article
January 1991

Elevated Plasma Norepinephrine Levels in Infants of Substance-Abusing Mothers

Author Affiliations

From the Division of Neonatology and Pediatric Pulmonology, Childrens Hospital of Los Angeles (Drs Ward and Warburton and Mss Bautista and Buckley); Los Angeles County—University of Southern California Medical Center (Drs Ward, Wachsman, and Warburton, and Ms Schuetz), Department of Pediatrics, University of Southern California School of Medicine (Mss Bautista and Buckley); and Martin Luther King, Jr, General Hospital, Charles R. Drew Postgraduate Medical School (Drs Bean and Sehgal), Los Angeles, Calif.

Am J Dis Child. 1991;145(1):44-48. doi:10.1001/archpedi.1991.02160010046014
Abstract

•Infants of substance-abusing mothers (ISAM) have significant growth and neurodevelopmental abnormalities. The origin of these abnormalities is unknown. We postulated that ISAM have increased sympathetic nervous system tone and altered catecholamine levels. Therefore, we measured plasma norepinephrine, epinephrine, and dopamine levels and the number and receptor affinity of β-adrenoreceptor binding sites on lymphocytes and α-adrenoreceptor binding sites on thrombocytes in 22 otherwise healthy ISAM (age, 2.1 ±0.5 months; mean±SD) and 15 healthy controls (age, 2.5 ±0.8 months). Norepinephrine levels in venous blood were 1.8-fold higher in ISAM than in control infants (6.30 ±3.85 nmol/L vs 3.55 ±2.45 nmol/L). There were no differences in plasma epinephrine or dopamine levels. There were no differences in the number of binding sites or receptor affinity for β- and α-adrenoreceptors. We conclude that ISAM have elevated circulating norepinephrine levels compared with controls. We speculate that this is associated with increased sympathetic nervous system tone in ISAM and that the absence of adrenoreceptor down-regulation may create catecholamine suprasensitivity.

(AJDC. 1991;145:44-48)

×